Protective effects of xyloglucan in association with the polysaccharide gelose in an experimental model of gastroenteritis and urinary tract infections

International Journal of Molecular Sciences

Volumn 19, Issue 7, 2018, Pages

  Esposito, Emanuela ^a   Campolo, Michela ^a   Casili, Giovanna ^a   Lanza, Marika ^a   Franco, Domenico ^a   Filippone, Alessia ^a   Peritore, Alessio F ^a   Cuzzocrea, Salvatore ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gastroenteritis; Gelose; Urinary tract infection; Xyloglucan

Indexed keywords

ARTICLE; BACTERIUM COLONY; CONTROLLED STUDY; DENSITOMETRY; ENTEROCOCCUS HIRAE; FECES; GASTROENTERITIS; IMMUNOHISTOCHEMISTRY; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERMEABILITY; PH; RAT; SALMONELLA ENTERICA; TIGHT JUNCTION; URINARY TRACT INFECTION; URINE VOLUME; ANIMAL; BACTERIAL INFECTION; DISEASE MODEL; DRUG EFFECT; HOST PATHOGEN INTERACTION; HUMAN; INTESTINE; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME FACTOR;

GLUCAN; POLYSACCHARIDE; XYLAN; XYLOGLUCAN;

ANIMALS; BACTERIAL INFECTIONS; DISEASE MODELS, ANIMAL; ENTEROCOCCUS HIRAE; GASTROENTERITIS; GLUCANS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTESTINES; POLYSACCHARIDES; RATS, SPRAGUE-DAWLEY; SALMONELLA ENTERICA; TIME FACTORS; URINARY TRACT INFECTIONS; XYLANS;

EID: 85049004135     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms19071844     Document Type: Article

References (42)

1. Cortes-Penfield, N.W.; Trautner, B.W.; Jump, R.L.P. Urinary Tract Infection and Asymptomatic Bacteriuria in Older Adults. Infect. Dis. Clin. N. Am. 2017, 31, 673–688. [CrossRef] [PubMed]
2. Skyum, F.; Andersen, V.; Chen, M.; Pedersen, C.; Mogensen, C.B. Infectious Gastroenteritis and the Need for Strict Contact Precaution Procedures in Adults Presenting in the Emergency Department—A Danish Register-based Study. J. Hosp. Infect. 2018, 98, 391–397. [CrossRef] [PubMed]
3. Finlay, B.B.; Brumell, J.H. Salmonella interactions with host cells: In vitro to in vivo. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2000, 355, 623–631. [CrossRef] [PubMed]
4. Eckmann, L.; Kagnoff, M.F.; Fierer, J. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect. Immun. 1993, 61, 4569–4574. [PubMed]
5. Jung, H.C.; Eckmann, L.; Yang, S.K.; Panja, A.; Fierer, J.; Morzycka-Wroblewska, E.; Kagnoff, M.F. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Investig. 1995, 95, 55–65. [CrossRef] [PubMed]
6. Gorelik, Y.; Paul, M.; Geffen, Y.; Khamaisi, M. Urinary Tract Infections Due to Nontyphoidal Salmonella. Am. J. Med. Sci. 2017, 353, 529–532. [CrossRef] [PubMed]
7. Gulcan, A.; Bayram, P.; Levent, B.; Gulcan, E. A case of urinary tract infection due to Salmonella enterica serovar Virchow and review of the related literature. Acta Microbiol. Immunol. Hung. 2012, 59, 85–89. [CrossRef] [PubMed]
8. Leung, A.K.; Kao, C.P.; Robson, W.L. Urinary tract infection due to Salmonella stanleyville in an otherwise healthy child. J. Natl. Med. Assoc. 2005, 97, 281–283. [PubMed]
9. Gilad, J.; Borer, A.; Riesenberg, K.; Peled, N.; Shnaider, A.; Schlaeffer, F. Enterococcus hirae septicemia in a patient with end-stage renal disease undergoing hemodialysis. Eur. J. Clin. Microbiol. Infect. Dis. 1998, 17, 576–577. [CrossRef] [PubMed]
10. Etheridge, M.E.; Yolken, R.H.; Vonderfecht, S.L. Enterococcus hirae implicated as a cause of diarrhea in suckling rats. J. Clin. Microbiol. 1988, 26, 1741–1744. [PubMed]
11. Bourafa, N.; Loucif, L.; Boutefnouchet, N.; Rolain, J.M. Enterococcus hirae, an unusual pathogen in humans causing urinary tract infection in a patient with benign prostatic hyperplasia: First case report in Algeria. New Microbes New Infect. 2015, 8, 7–9. [CrossRef] [PubMed]
12. Di Lodovico, S.; Cataldi, V.; Di Campli, E.; Ancarani, E.; Cellini, L.; Di Giulio, M. Enterococcus hirae biofilm formation on hospital material surfaces and effect of new biocides. Environ. Health Prev. Med. 2017, 22, 63. [CrossRef] [PubMed]
13. Gupta, A.; Dwivedi, M.; Mahdi, A.A.; Nagana Gowda, G.A.; Khetrapal, C.L.; Bhandari, M. Inhibition of adherence of multi-drug resistant E. coli by proanthocyanidin. Urol. Res. 2012, 40, 143–150. [CrossRef] [PubMed]
14. Howell, A.B. Cranberry proanthocyanidins and the maintenance of urinary tract health. Crit. Rev. Food Sci. Nutr. 2002, 42 (Suppl. 3), 273–278. [CrossRef] [PubMed]
15. Howell, A.B.; Botto, H.; Combescure, C.; Blanc-Potard, A.B.; Gausa, L.; Matsumoto, T.; Tenke, P.; Sotto, A.; Lavigne, J.P. Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: A multicentric randomized double blind study. BMC Infect. Dis. 2010, 10, 94. [CrossRef] [PubMed]
16. Chisholm, A.H. Probiotics in Preventing Recurrent Urinary Tract Infections in Women: A Literature Review. Urol. Nurs. 2015, 35, 18–21, 29. [PubMed]
17. De Servi, B.; Ranzini, F.; Pique, N. Effect of Utipro((R)) (containing gelatin-xyloglucan) against Escherichia coli invasion of intestinal epithelial cells: Results of an in vitro study. Future Microbiol. 2016, 11, 651–658. [CrossRef] [PubMed]
18. Salvatorelli, N.; Garcia-Larrosa, A.; Allegrini, A.; Pavone, D. A New Approach to the Treatment of Uncomplicated Cystitis: Results of a Randomized Placebo-Controlled Clinical Trial. Urol. Int. 2016, 97, 347–351. [CrossRef] [PubMed]
19. Gnessi, L.; Bacarea, V.; Marusteri, M.; Pique, N. Xyloglucan for the treatment of acute diarrhea: Results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial. BMC Gastroenterol. 2015, 15, 153. [CrossRef] [PubMed]
20. Plesea Condratovici, C.; Bacarea, V.; Pique, N. Xyloglucan for the Treatment of Acute Gastroenteritis in Children: Results of a Randomized, Controlled, Clinical Trial. Gastroenterol. Res. Pract. 2016, 2016, 6874207. [CrossRef] [PubMed]
21. Pique, N.; Gomez-Guillen, M.D.C.; Montero, M.P. Xyloglucan, a Plant Polymer with Barrier Protective Properties over the Mucous Membranes: An Overview. Int. J. Mol. Sci. 2018, 19, 673. [CrossRef] [PubMed]
22. Fraile, B.; Alcover, J.; Royuela, M.; Rodriguez, D.; Chaves, C.; Palacios, R.; Pique, N. Xyloglucan, hibiscus and propolis for the prevention of urinary tract infections: Results of in vitro studies. Future Microbiol. 2017, 12, 721–731. [CrossRef] [PubMed]
23. Wang, Y.; Dong, M.; Guo, M.; Wang, X.; Zhou, J.; Lei, J.; Guo, C.; Qin, C. Agar/gelatin bilayer gel matrix fabricated by simple thermo-responsive sol-gel transition method. Mater. Sci. Eng. C Mater. Biol. Appl. 2017, 77, 293–299. [CrossRef] [PubMed]
24. Wu, C.; Zhao, J.; Hu, F.; Zheng, Y.; Yang, H.; Pan, S.; Shi, S.; Chen, X.; Wang, S. Design of injectable agar-based composite hydrogel for multi-mode tumor therapy. Carbohydr. Polym. 2018, 180, 112–121. [CrossRef] [PubMed]
25. Franceschi, F.; Scaldaferri, F.; Riccioni, M.E.; Casagranda, I.; Forte, E.; Gerardi, V.; Cordischi, C.; Antonini, S.; Tortora, A.; Di Rienzo, T.; et al. Management of acute dyarrhea: Current and future trends. Eur. Rev. Med. Pharmacol. Sci. 2014, 18, 2065–2069. [PubMed]
26. Ruszczynski, M.; Urbanska, M.; Szajewska, H. Gelatin tannate for treating acute gastroenteritis: A systematic review. Ann. Gastroenterol. 2014, 27, 121–124. [PubMed]
27. Alexea, O.; Bacarea, V.; Pique, N. The combination of oligo-and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: Results of a randomised, placebo-controlled, double-blind, parallel group, multicentre clinical trial. United Eur. Gastroenterol. J. 2016, 4, 455–465. [CrossRef] [PubMed]
28. Jones, B.D.; Falkow, S. Salmonellosis: Host immune responses and bacterial virulence determinants. Annu. Rev. Immunol. 1996, 14, 533–561. [CrossRef] [PubMed]
29. Sinha, R.; Howlader, D.R.; Mukherjee, P.; Rai, S.; Nag, D.; Koley, H. Retinoic acid decreases the severity of Salmonella enterica serovar Typhimurium mediated gastroenteritis in a mouse model. Immunobiology 2016, 221, 839–844. [CrossRef] [PubMed]
30. Barthel, M.; Hapfelmeier, S.; Quintanilla-Martinez, L.; Kremer, M.; Rohde, M.; Hogardt, M.; Pfeffer, K.; Russmann, H.; Hardt, W.D. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 2003, 71, 2839–2858. [CrossRef] [PubMed]
31. Finlay, B.B.; Falkow, S. Salmonella interactions with polarized human intestinal Caco-2 epithelial cells. J. Infect. Dis. 1990, 162, 1096–1106. [CrossRef] [PubMed]
32. Jepson, M.A.; Collares-Buzato, C.B.; Clark, M.A.; Hirst, B.H.; Simmons, N.L. Rapid disruption of epithelial barrier function by Salmonella typhimurium is associated with structural modification of intercellular junctions. Infect. Immun. 1995, 63, 356–359. [PubMed]
33. Tafazoli, F.; Magnusson, K.E.; Zheng, L. Disruption of epithelial barrier integrity by Salmonella enterica serovar typhimurium requires geranylgeranylated proteins. Infect. Immun. 2003, 71, 872–881.
34. Fasano, A. Toxins and the gut: Role in human disease. Gut 2002, 50 (Suppl. 3), III9–III14. [CrossRef] [PubMed]
35. Hecht, G. Microbes and microbial toxins: Paradigms for microbial-mucosal interactions. VII. Enteropathogenic Escherichia coli: Physiological alterations from an extracellular position. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 281, G1–G7. [CrossRef] [PubMed]
36. Tzipori, S.; Hayes, J.; Sims, L.; Withers, M. Streptococcus durans: An unexpected enteropathogen of foals. J. Infect. Dis. 1984, 150, 589–593. [CrossRef] [PubMed]
37. Hoover, D.; Bendele, S.A.; Wightman, S.R.; Thompson, C.Z.; Hoyt, J.A. Streptococcal enteropathy in infant rats. Lab. Anim. Sci. 1985, 35, 635–641. [PubMed]
38. Boopathy, V.; Periyasamy, S.; Alexander, T.; Balasubramanian, P. Typhoid fever with caecal ulcer bleed: Managed conservatively. BMJ Case Rep. 2014, 2014. [CrossRef] [PubMed]
39. Ten Bruggencate, S.J.; Bovee-Oudenhoven, I.M.; Lettink-Wissink, M.L.; Katan, M.B.; Van Der Meer, R. Dietary fructo-oligosaccharides and inulin decrease resistance of rats to salmonella: Protective role of calcium. Gut 2004, 53, 530–535. [CrossRef] [PubMed]
40. Bovee-Oudenhoven, I.M.; Termont, D.S.; Heidt, P.J.; Van der Meer, R. Increasing the intestinal resistance of rats to the invasive pathogen Salmonella enteritidis: Additive effects of dietary lactulose and calcium. Gut 1997, 40, 497–504. [CrossRef] [PubMed]
41. Mullane, K.M.; Kraemer, R.; Smith, B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Methods 1985, 14, 157–167. [CrossRef]
42. Esposito, E.; Impellizzeri, D.; Mazzon, E.; Paterniti, I.; Cuzzocrea, S. Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson’s disease. PLoS ONE 2012, 7, e41880. [CrossRef] [PubMed]